(Stroke. 1995;26:1901-1907.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Neurosurgery, Hyogo College of Medicine (M.Y., E.T.), the Department of Molecular Biology, Tokyo Metropolitan Institute of Medical Science (T.C.S., S.K.), and the Institute of Applied Microbiology, University of Tokyo (K.S.), Japan.
Correspondence to Masayuki Yokota, MD, Department of Neurosurgery, Hyogo College of Medicine, Mukogawa-cho 1-1 Nishinomiya, Hyogo, 663 Japan.
| Abstract |
|---|
|
|
|---|
Methods In gerbils, a 10-minute forebrain ischemia was produced by occlusion of both carotid arteries. After recirculation, the hippocampus was processed for immunohistochemical and immunoblot study with the antibody against the calpain-proteolyzed form of fodrin. Additionally, short-term ischemia was studied to find the threshold of fodrin proteolysis.
Results Three phases of fodrin proteolysis distinct in chronology and distribution arose: (1) an early predegeneration phase in the molecular layer and stratum oriens of the CA1 and CA3 sectors within the first 15 minutes, which lasted up to 4 hours; (2) a late predegeneration phase in the whole CA1 sector, except for the pyramidal cells, between 12 hours and 2 days; and (3) a postdegeneration phase in the cytoplasm of the CA1 neurons, which arose in 3 to 7 days. A 4-minute (not a 3-minute) forebrain ischemia induced the late predegeneration phase of fodrin proteolysis and delayed neuronal death in CA1. Immunoblotting showed that the primary product of calpain action was further proteolyzed by an unidentified protease.
Conclusions Calpain induced proteolysis of fodrin in ischemic hippocampus, and the late predegeneration phase of the proteolysis was closely associated with the delayed neuronal death in the CA1 sector. Calpain and another protease may play a role in the development of neuronal death after transient forebrain ischemia.
Key Words: calpain cerebral ischemia fodrin proteolysis hippocampus
| Introduction |
|---|
|
|
|---|
-amino-3-hydroxy-5-methyl-4-isoxazolepropionate) and
kainate. Stimulation of NMDA and metabotropic receptors causes
influx of Ca2+ and activates intracellular
Ca2+-dependent cysteine protease, µ-calpain,
which is enriched in the central nervous system.7 8 9 The
activated calpain selectively proteolyzes substrate proteins in
a limited manner.10 Among the calpain-specific
substrates, fodrin, a major cytoskeletal protein underlying the plasma membranes
in brain,11 12 has been most extensively described in
pathophysiological situations. Fodrin undergoes
calpain-catalyzed proteolysis both in long-term potentiation
and postischemic degeneration.13 14
Consequently, its
-subunit of 230 kD is converted to a 150-kD
fragment.12 15 On the basis of these observations, we devised a means of capturing the proteolytic process by developing an antibody that specifically distinguishes the proteolyzed fodrin from the intact one.16 Taking advantage of the approach that finally enabled us to analyze the process in spatial terms, we demonstrated that transient ischemia induces at least two distinct phases of fodrin proteolysis in the hippocampus: an early phase in the molecular layer and in the stratum oriens of the CA3 and CA1 sectors arising within the first 15 minutes and a late phase in the entire CA1 sector 4 to 24 hours later. In the present study, we made a more detailed analysis and discovered another distinct phase of fodrin proteolysis that arose along with the neuronal degeneration. Furthermore, we intend to show that the predegeneration phase actually participates in the pathological cascade leading to neuronal death. We also describe our new discovery as to how a secondary proteolytic product derived from the calpain-proteolyzed fodrin accumulates in postischemic brain, raising a new possibility in interpreting the pathological mechanism.
| Materials and Methods |
|---|
|
|
|---|
In addition, to clarify the threshold of ischemic duration for delayed neuronal death, a short period of forebrain ischemia was induced. Four animals from each group underwent 2, 3, or 4 minutes of transient forebrain ischemia and were killed at same intervals as the animals with 10 minutes of ischemia. The sections of hippocampus were processed for immunohistochemistry.
To assess tissue architecture, we prepared 5-µm sections from each hippocampus after the fixation and stained them with cresyl violet. The number of neurons in the linear length (1 mm) of the CA1 pyramidal layer (neuronal cell density) was counted in each specimen, according to the method of Kirino et al.17
Preparation of the antibody specific for the calpain-proteolyzed
150-kD form of fodrin's
subunit was described previously, and its
character has been thoroughly studied.16 The
antihuman fodrin
subunit PEST
(proline-glutamate/aspartate-serine-threonine-rich)
sequence antibody,15 which recognizes both the intact
230-kD and proteolyzed 150-kD forms, was also used for the
immunohistochemistry and immunoblot analysis. Antigenic
epitopes of both the antibodies are shown in Fig 1
.
|
The animals were carefully handled in a humane fashion and our experimental protocols met the US Public Health Service standards described in the 1985 Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
Immunohistochemistry
Immunohistochemistry was performed essentially as previously
described. In brief, the fixed brains were coronally sectioned at 20
µm on a cryostat. Each section was preincubated with 3% normal goat
serum and 0.3% hydrogen peroxide in PBS for 30 minutes at room
temperature. The sections were then incubated with the antibody to the
proteolyzed form of fodrin or to the PEST sequence (1 µg/mL) at room
temperature for 1 night. After being rinsed, sections were incubated
with biotinylated goat anti-rabbit IgG (Vector) for 2 hours and
then with ABC-peroxidase complex (Vector) for 2 hours at room
temperature. After rinsing of the sections, immunolabel was visualized
with 0.015% diaminobenzidine tetrahydrochloride (Sigma) and 0.003%
hydrogen peroxide in 50 mmol/L Tris/HCl buffer (pH 7.6).
Immunoblotting
For immunoblot analysis, nine animals treated with a
10-minute ischemia period were perfused with Tris/HCl buffer
(pH 7.6) containing 5 mmol/L EDTA, 5 mmol/L ß-mercaptoethanol,
250 mmol/L sucrose, and 0.1 mmol/L leupeptin at intervals of 15
minutes, 1 day, and 7 days (three animals at each interval).
Furthermore, three sham-operated animals were perfused in the same
fashion 1 day after the operation. The hippocampus was dissected and
immersed in liquid nitrogen, and remained frozen at -85°C until
further processing. Western blotting was performed by use of both the
antibodies as described in the previous study.15 18 One
hippocampus in each group was used in every blotting. Each immunolabled
band was densitometrically quantitated by a videodensitometry system
(ACI Japan).
Statistics
Statistical comparisons were made by two-tailed Student's
t test for unpaired variates.
| Results |
|---|
|
|
|---|
|
|
In the hippocampus of the sham-treated animals, immunoreactivity
corresponding to the 150-kD proteolytic fragment of fodrin (150kD-IR)
was below detectable levels (Fig 3A
). Within 15 minutes
after the reperfusion, 150kD-IR appeared in the neuropil of the stratum
lacunosum moleculare, the stratum oriens of the CA3 sector, and the
stratum oriens of the CA1 sector (Fig 3B
), and it remained until around
4 hours after the reperfusion, as previously described.16
Between 6 to 12 hours, additional fodrin proteolysis was observed in
the entire CA1 sector (Fig 3C
), except for the soma and dendrites of
the pyramidal neurons (Fig 4A
), although no
immunoreactivity was observed in the hilus and stratum lucidum where
mossy fibers pass. One day after the ischemic insult, the
proteolysis was observed only in the entire CA1 sector, and it remained
until day 2 (Fig 3D
). These two distinct phases are referred to here as
the early and late predegeneration phases because we have now
discovered a third phase that was initiated at the time of the actual
neuronal degeneration.
|
|
Fig 4B
shows that the soma and dendrites of the pyramidal
neurons in the medial part of the CA1 sector (CA1a) became positive for
150kD-IR, while the lateral part (CA1b) showed very little
immunoreactivity on day 3 (Fig 3E
). This fodrin proteolysis seems to
have arisen as a result of cell death because the CA1a cells had
started to degenerate with shrunken and hyperchromatic morphology by
this time, as shown by cresyl violet staining (Fig 2B
). Seven days
after the ischemia, all the CA1 neurons were degenerated and
some debris of CA1 neurons showed dense 150kD-IR with moderately dense
immunoreactivity in other CA1 regions (Fig 3F
). Apparently, this fodrin
proteolysis within pyramidal cells followed the dying
processes and was therefore referred to as the postdegeneration phase.
Each group showed a consistent tendency in the pattern of
immunohistochemical staining, although its intensity varied in some
cases. Immunoblot analysis confirmed the presence of the 150-kD
fragment of fodrin in postischemic brain for up to 7 days
(see below). Throughout the experiment, CA4 neurons, the dentate gyrus,
and the stratum lucidum showed no 150kD-IR, supporting the hypothesis
that calpain plays essential roles in the postischemic
pathological cascade.14 16 Intact fodrin immunoreactivity
stained with anti-PEST antibody showed uniform distribution in the
whole hippocampus (Fig 5
). The soma and dendrites of the
pyramidal neurons in all CA sectors and dentate granule
cells showed heavy immunoreactivity (Fig 5A
). Little change was
observed after the ischemia until day 3 (Fig 5B
, 5C
, and 5D
).
Three days after the insult, the immunoreactivity was faded in the soma
and dendrites of the pyramidal neurons in the CA1a sector
(Fig 5E
), and on day 7 reduction of the immunoreactivity spread all
over the CA1 sector (Fig 5F
). These findings represent a small
amount of the intact fodrin in the hippocampus, of which distribution
was shown as the late predegeneration phase in immunohistochemical
study with antiproteolyzed fodrin antibody, and it was
proteolyzed after the ischemia.
|
With the aim of determining which of the predegeneration phases is
responsible for the subsequent delayed neuronal death, we examined the
effect of the ischemic duration on fodrin proteolysis and cell
death (Fig 6
) with the knowledge that a critical time
point determining life or death of neurons exists around 3 to 4
minutes.19 Short-term ischemia of less than 3
minutes did not induce delayed neuronal death in the CA1 sector (Table 1
). On the contrary, the early predegeneration phase of fodrin
proteolysis in the CA3 sector was observed even under these conditions,
suggesting that proteolysis of fodrin at this stage is insufficient to
cause the delayed death of neurons. In clear contrast, the late
predegeneration phase of proteolysis paralleled the cell death;
fodrin proteolysis in the entire CA1 at 24 hours arose only under the
conditions that induced neuronal degeneration: ie, a 4-minutelong
ischemia. The postdegeneration proteolysis obviously correlated
well with the cell death because it appeared only in dying and dead
neurons (data not shown). These results suggest that the late
predegeneration phase may play critical roles in the
postischemic pathological cascade and present important
medical implications (see "Discussion").
|
Finally, we analyzed the proteolytic products of fodrin in
the postischemic hippocampus by immunoblotting with the
anti-fodrin antibodies recognizing distinct sites of the molecule
(Fig 1
). Each immunoblot study showed a constant tendency, as shown in
Table 2
. In accordance with our previous
report,16 a 150-kD fragment recognized by both of the
antibodies was produced in postischemic hippocampus
throughout the entire experiments, although its amount gradually
decreased (Fig 7
). Notably, a smaller fragment of
approximately 130 kD recognized by the anti-PEST sequence antibody was
also produced in the postischemic hippocampus (Fig 7B
).
Because this fragment was not recognized by the antiproteolyzed
fodrin antibody, it is devoid of the amino-terminal portion of the
150-kD fragment. Concomitantly, a smaller fragment of 20 kD recognized
by the antiproteolyzed fodrin antibody, but not by the anti-PEST
sequence antibody, increased, particularly at 24 hours after
ischemia (Fig 7A
), presumably representing the
amino-terminal fragment produced by this secondary proteolysis.
Because the distance between the cleavage site attacked by calpain and
the location of the PEST sequence is close to 20 kD,20 21
these data suggest that fodrin was proteolyzed through two steps, as
shown in Fig 8
. Importantly, this 20-kD product
presumably contains the entire calmodulin-binding
segment and would no longer bind to actin filaments. It may be simply
complicated with calmodulin in cytoplasm under
postischemic circumstances with elevated
[Ca2+]i. We should not, however,
overestimate the amount of this 20-kD fragment relative to that of the
150-kD fragment in interpreting the immunohistochemical data, because
the efficiency of electroblotting decreases as the molecular weight of
protein increases. The difference in blotting efficiency between 150-kD
and 20-kD proteins could vary by a factor of 10 or more. We should
therefore view the immunohistochemical data as showing the 150-kD and
20-kD fragments together.
|
|
|
The finding of the secondary proteolysis raises the question of the
identity of the protease involved. Calpain does not usually produce the
130-kD fragment of the fodrin
subunit in test
tubes.12 15 Therefore, an unidentified protease other than
calpain is likely to be responsible for this process, although we
cannot totally exclude calpain as a candidate protease because its
action could be varied under the specific in vivo conditions.
| Discussion |
|---|
|
|
|---|
Hippocampal CA1 neurons are located at the end of a trisynaptic
chain of excitatory synapses that consists of dentate granule cells,
CA3 neurons, and CA1 neurons. Many reports demonstrate that the
trisynaptic chain is closely involved in development of delayed
neuronal death.29 30 We also demonstrated that two kinds
of protein kinase are activated in the gerbil trisynaptic chain
after forebrain ischemia.31 32 However, in this
study the proteolysis of fodrin was not observed in the dentate gyrus
and mossy fiber system throughout the time course (Fig 3
), whereas
intact fodrin exists in the whole hippocampus (Fig 5
). This may be due
to lack of Ca2+ accumulation in the dentate gyrus
after the ischemia.33 Amaral and
Witter34 showed that CA3 pyramidal neurons
receive input directly from the perforant path, not via the dentate
gyrus and mossy fibers. Therefore, our results may indicate that a
pathway other than a trisynaptic chain of excitatory synapses is
involved in the development of the delayed neuronal death.
We have demonstrated that short-term (less than 3 minutes) forebrain ischemia, which does not induce delayed neuronal death, produces an early but not a late predegeneration phase of proteolysis. In contrast, the long-term (more than 4 minutes) forebrain ischemia, which consistently induces delayed neuronal death, produced both early and late predegeneration phases of proteolysis. These observations suggest that the late predegeneration phase of fodrin-proteolysis is closely associated with the development of the delayed degeneration of CA1 pyramidal cells. This observation is in agreement with the report that Ca2+ accumulation is observed in the CA1 sector between 2 and 7 days after the 10-minute forebrain ischemia,33 which may continuously activate calpain and cause proteolysis of the fodrin. It is difficult to clarify whether calpain-degraded fodrin has any pathological role in the ischemic neuronal damage or is just a marker for calpain activation. Calpain-degraded fodrin causes morphological changes in erythrocytes,35 and it may play a role in development of long-term potentiation.36 However, its pathological role has not been reported. Microinjection of it into the CA1 sector may be useful to examine its toxicity. Lee et al37 demonstrated that an inhibitor of calpain protected ischemic neuronal damage and proteolysis of fodrin. Therefore, activation of calpain is closely involved in development of ischemic neuronal death, at least as a mediator of the pathological signals stated above. At any rate, if this late predegeneration phase proves to play an essential rate-limiting role, inhibition of calpain action before this stage in postischemic brain could be a possible therapeutic strategy in clinical medicine, giving hope for a successful postinjury treatment. Certainly further studies to evaluate, for instance, the effect of calpain inhibitors on specific proteolysis and cell death will be necessary to establish this assumption.
Finally, we have discovered a secondary processing of fodrin in postischemic brain by which the 150-kD fragment produced by calpain action is further converted to 130-kD and 20-kD fragments. Because the 20-kD fragment seems to carry an entire calmodulin-binding segment and because its localization would no longer be restricted to cytoskeletal structures, it may play a specialized role in the pathological cascade by associating with calmodulin. It is also possible that conversion of the 150-kD fragment to a 130-kD fragment may destabilize the protein structure and thus facilitate further degradation. Identification of the protease responsible for this step would be a subject of future studies.
Received March 13, 1995; revision received May 23, 1995; accepted June 16, 1995.
| References |
|---|
|
|
|---|
2. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43:1369-1374. [Medline] [Order article via Infotrieve]
3. Benveniste H, Jorgensen MB, Sanberg M, Christensen T, Hagberg H, Diemer NH. Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3. J Cereb Blood Flow Metab. 1989;9:628-639.
4.
Busto R, Globus MYT, Dietrich WD, Martinez E, Valdes
I, Ginsberg MD. Effect of mild hypothermia on
ischemia-induced release of neurotransmitters and free
fatty acids in rat brain. Stroke. 1989;20:904-910.
5. Hagberg H, Lehmann A, Sandberg M, Nystrom B, Jacobson I, Hamberger A. Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J Cereb Blood Flow Metab. 1985;5:413-419. [Medline] [Order article via Infotrieve]
6. Monaghan DT, Cotman CW. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci. 1985;5:2909-2919. [Abstract]
7. Fukuda T, Adachi E, Kawashima S, Yoshida I, Hashimoto PH. Immunohistochemical distribution of calcium-activated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus. J Comp Neurol. 1990;302:100-109. [Medline] [Order article via Infotrieve]
8. Hamakubo T, Kannagi R, Murachi T, Matus A. Distribution of calpains I and II in rat brain. J Neurosci. 1986;6:3103-3111. [Abstract]
9. Perlmutter LS, Gall C, Baudry M, Lynch G. Distribution of calcium-activated protease calpain in the rat brain. J Comp Neurol. 1990;296:269-276. [Medline] [Order article via Infotrieve]
10. Saido TC, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 1994;8:814-822. [Abstract]
11.
Levine J, Willard M. Fodrin: axonally
transported polypeptides associated with the internal periphery of many
cells. J Cell Biol. 1981;90:631-643.
12.
Siman R, Baudry M, Lynch G. Brain fodrin:
substrate for calpain I and endogenous
calcium-activated protease. Proc Natl Acad
Sci U S A. 1984;81:3572-3576.
13. Lynch G, Muller D. Steps between the induction and expression of long-term potentiation. In: Guidotti A, ed. Neurotoxicity of Excitatory Amino Acids. New York, NY: Raven Press; 1990:125-143.
14. Seubert P, Lee K, Lynch G. Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res. 1989;492:366-370. [Medline] [Order article via Infotrieve]
15.
Saido TC, Shibata M, Takenawa T, Murofushi H, Suzuki K.
Positive regulation of µ-calpain action by
polyphosphoinositides. J
Biol Chem. 1992;267:24585-24590.
16.
Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tuchiya
T, Suzuki K, Kawashima S. Spatial resolution of fodrin
proteolysis in postischemic brain. J
Biol Chem. 1993;268:25239-25243.
17.
Kirino T, Tamura A, Sano K. A reversible type of
neuronal injury following ischemia in the gerbil
hippocampus. Stroke. 1986;17:455-459.
18.
Saido TC, Nagao S, Shiramine M, Tsukaguchi M, Sorimachi
H, Murofushi H, Tuchiya T, Ito H, Suzuki K. Autolytic transition
of µ-calpain upon activation as resolved by antibodies
distinguishing between the pre- and post-autolysis forms.
J Biochem (Tokyo). 1992;111:81-86.
19. Kirino T, Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol (Berlin). 1984;62:201-208. [Medline] [Order article via Infotrieve]
20.
McMahon AP, Moon RT. Structure and evolution of
a non-erythroid spectrin human
-fodrin.
Biochem Soc Trans. 1987;15:804-807. [Medline]
[Order article via Infotrieve]
21. Wang KKW, Villalobo A, Roufogalis BD. Calmodulin-binding proteins as calpain substrates. Biochem J. 1989;262:693-706.[Medline] [Order article via Infotrieve]
22. Glenney JR, Glenney P, Osborn M, Weber K. An F-actin- and calmodulin-binding protein from isolated intestinal brush borders has a morphology related to spectrin. Cell. 1982;28:843-854. [Medline] [Order article via Infotrieve]
23. Siman R, Baudry M, Lynch G. Regulation of glutamate receptor binding by the cytoskeletal protein fodrin. Nature. 1985;313:225-228. [Medline] [Order article via Infotrieve]
24.
Wang C, Walsh MP, Wang JH. Effect of
phosphorylation by cyclic AMP-dependent protein kinase
on the smooth muscle actomyosin Mg2+-ATPase
stimulatory activity of fodrin. J Biol
Chem. 1987;262:14716-14722.
25. Kasuga M, Izumi T, Tobe K, Shibata T, Momomura K, Tashiro-Hashimoto Y. Substrates for insulin-receptor kinase. Diabetes Care. 1990;13:317-326. [Abstract]
26. Wang C, Kong SK, Wang JH. Characterization of fodrin phosphorylation by spleen protein tyrosine kinase. Biochemistry. 1988;27:1254-1260.[Medline] [Order article via Infotrieve]
27. Burns NR. Skeleton key to memory? Nature. 1985;313:178-179. [Medline] [Order article via Infotrieve]
28. Kosower NS, Glaser T. The calpain-calpastatin system and membrane fusion. In: Mellgren RL, Murachi T, eds. Intracellular Calcium-Dependent Proteolysis. Boca Raton, Fla: CRC Press; 1990:163-180.
29. Johansen FF, Jorgensen MB, Diemer NH. Ischemic CA-1 pyramidal cell loss is prevented by preischemic colchicine destruction of dentate gyrus granule cells. Brain Res. 1986;377:344-347. [Medline] [Order article via Infotrieve]
30. Wieloch T, Lindvall O, Blomqvist P, Gage FH. Evidence of amelioration of ischaemic neuronal damage in the hippocampal formation by lesions of the perforant path. Neurol Res. 1985;7:24-26. [Medline] [Order article via Infotrieve]
31. Yokota M, Peterson JW, Kaoutzanis M, Kowall NW. The immunohistochemical distribution of protein kinase C isozymes is differentially altered in ischemic gerbil hippocampus. Brain Res. 1992;587:123-129. [Medline] [Order article via Infotrieve]
32. Yokota M, Saido TC, Miyaji K, Tani E, Kawashima S, Suzuki K. Stimulation of protein-tyrosine phosphorylation in gerbil hippocampus after global forebrain ischemia. Neurosci Lett. 1994;168:69-72. [Medline] [Order article via Infotrieve]
33. Araki T, Kato H, Kogure K. Selective neuronal vulnerability following transient cerebral ischemia in the gerbil: distribution and time course. Acta Neurol Scand. 1989;80:548-553. [Medline] [Order article via Infotrieve]
34. Amaral DG, Witter MP. The three-dimensional organization of the hippocampal formation: a review of anatomical data. Neuroscience. 1989;31:571-591. [Medline] [Order article via Infotrieve]
35. Hayashi M, Inomata M, Saito Y, Ito H, Kawashima S. Activation of intracellular calcium-activated neutral proteinase in erythrocytes and its inhibition by exogenously added inhibitors. Biochim Biophys Acta. 1991;1094:249-256. [Medline] [Order article via Infotrieve]
36. Lynch G, Muller D, Seubert P, Larson J. Long-term potentiation: persisting problems and recent results. Brain Res Bull. 1988;21:363-372. [Medline] [Order article via Infotrieve]
37.
Lee KL, Frank S, Vanderklish P, Arai A, Lynch G.
Inhibition of proteolysis protects hippocampal neurons from
ischemia. Proc Natl Acad Sci U S A. 1991;88:7233-7237.
This article has been cited by other articles:
![]() |
E. Nakajima, L. L. David, C. Bystrom, T. R. Shearer, and M. Azuma Calpain-Specific Proteolysis in Primate Retina: Contribution of Calpains in Cell Death Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5469 - 5475. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Farkas, J. Lifshitz, and J. T. Povlishock Mechanoporation induced by diffuse traumatic brain injury: an irreversible or reversible response to injury? J. Neurosci., March 22, 2006; 26(12): 3130 - 3140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takano, M. Tomioka, S. Tsubuki, M. Higuchi, N. Iwata, S. Itohara, M. Maki, and T. C. Saido Calpain Mediates Excitotoxic DNA Fragmentation via Mitochondrial Pathways in Adult Brains: EVIDENCE FROM CALPASTATIN MUTANT MICE J. Biol. Chem., April 22, 2005; 280(16): 16175 - 16184. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lipton Ischemic Cell Death in Brain Neurons Physiol Rev, October 1, 1999; 79(4): 1431 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Shackelford, T. Tobaru, S. Zhang, and J. A. Zivin Changes in Expression of the DNA Repair Protein Complex DNA-Dependent Protein Kinase after Ischemia and Reperfusion J. Neurosci., June 15, 1999; 19(12): 4727 - 4738. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Guttmann and G. V. W. Johnson Oxidative Stress Inhibits Calpain Activity in Situ J. Biol. Chem., May 22, 1998; 273(21): 13331 - 13338. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Markgraf, N. L. Velayo, M. P. Johnson, D. R. McCarty, S. Medhi, J. R. Koehl, P. A. Chmielewski, M. D. Linnik, and J. A. Clemens Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in Rats • Editorial Comment Stroke, January 1, 1998; 29(1): 152 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Vanags, M. I. Porn-Ares, S. Coppola, D. H. Burgess, and S. Orrenius Protease Involvement in Fodrin Cleavage and Phosphatidylserine Exposure in Apoptosis J. Biol. Chem., December 6, 1996; 271(49): 31075 - 31085. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |